Related Experiment Video
Updated: Feb 8, 2026

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal
Published on: October 11, 2019
Flexible Non-Negative Matrix Factorization to Unravel Disease-Related Genes
Abstract:
Recently, non-negative matrix factorization (NMF) has been shown to perform well in the analysis of omics data. NMF assumes that the expression level of one gene is a linear additive composition of metagenes. The elements in metagene matrix represent the regulation effects and are restricted to non-negativity. However, according to the real biological meaning, there are two kinds of regulation effects, i.e., up-regulation and down-regulation. Few methods based on NMF have considered this biological meaning. Therefore, we designed a flexible non-negative matrix factorization (FNMF) algorithm by further considering the biological meaning of gene expression data. It allows negative numbers in the metagene matrix, and negative numbers represent down-regulation effects. We separated gene expression data into disease-driven gene expression and background gene expression. Subsequently, we computed disease-driven gene relative expression, and a ranked list of genes was obtained. The top ranked genes are considered to be involved in some disease-related biological processes. Experimental results on two real-world gene expression data demonstrate the feasibility and effectiveness of FNMF. Compared with conventional disease-related gene identification algorithms, FNMF has superior performance in analyzing gene expression data of diseases with complex pathology.
Related Concept Videos
Negative Regulator Molecules
The Extracellular Matrix
Factors Influencing Drug Absorption: Disease States and Pharmacology
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Transcription Factors
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

